Y-Q. Cao and M.R. Bruchas. Washington Univ. Sch. of Med.
W68
1173.5 Phosphorylation and internalization of short
splicing variant of the omega 3 fatty acid sensor,GPR120.
O.B.
Sanchez-Reyes, J.A. Castillo-Badillo, M.T. Romero-Avila,
Y. Takei, A. Hirasawa, G. Tsujimoto, R. Villalobos-Molina
and J.A. García-Sáinz. UNAM, Mexico City, Grad. Sch. of
Pharmaceut. Sci. , Kyoto Univ. and Col. Fac.-Iztacala, UNAM,
Tlalnepantla.
W69
1173.6 Visualizing trafficking of the adenosine-A
3
receptor using a fluorescent agonist: a tool for delineating
intracellular signaling.
S. Briddon, L. Stoddart, A. Vernall, B.
Kellam and S. Hill. Univ. of Nottingham, U.K.
W70
1173.7 ADAM17 regulates sphingosine 1 phosphate
receptor 1 cell surface expression and downstream signaling.
B.V. Desai, A. Ludwig, A.B. Malik and D. Mehta. Univ. of
Illinois at Chicago and RWTH Aachen Univ., Germany.
PHARMACOLOGY WEDNESDAY
415
W
E
D
W71
1173.8 PDZ ligand-dependent phosphorylation of
Ser
336
in the C-terminal tail of the P2Y
1
receptor blocks agonist-
promoted internalization in HEK293 cells.
R.A. Nicholas, K.
Harden and A-D. Qi. Univ. of North Carolina at Chapel Hill and
Vanderbilt Univ.
W72
1173.9 A role for endothelin converting enzyme-1
activity in the regulation of neuromedin U receptor re-
sensitization and ERK signaling.
K. Alhosaini, R.A.J. Challiss
and G.B. Willars. Col. of Pharm., King Saud Univ., Saudi
Arabia and Univ. of Leicester, U.K.
W73
1173.10 Role of AKAP79 in
b1-adrenergic receptor
resensitization and recycling.
X. Li and S.W. Bahouth. Univ. of
Tennessee, Memphis.
W74
1173.11 Cannabinoid receptor interacting protein 1a
regulates CB1 receptor trafficking.
L.C. Blume, G.D. Dalton,
D.E. Selley and A.C. Howlett. Wake Forest Baptist Hlth. and
Virginia Commonwealth Univ.
W75
1173.12 Use of membrane permeable ligands as
pharmacological chaperones to rescue the plasma membrane
expression of a mutant muscarinic M
1
receptor.
G.W. Sawyer
and C. Shults. Oklahoma State Univ.
W76
1173.13 Mouse Flower-like, a membrane protein
involved in endocytosis?
S. Mannebach-Götz, K. Frohnweiler,
U. Wissenbach and V. Flockerzi. Univ. of Saarland, Germany.
1174. RECEPTOR NEUROPHARMACOLOGY
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W77
1174.1 A new potent and specific 5-HT2C receptor
agonist with preclinical anti-psychotic and anti-obesity
properties.
C. Canal, D. Morgan, K. Kondabolu, N. Rowland
and R. Booth. Northeastern Univ. and Univ. of Florida.
W78
1174.2 Selective allosteric modulation of the 5-HT3A
receptor by halogenated indole derivates.
N. Barnes, A.
Chiarenza, S. Gambassi, A. Powell and G. Grafton. Univ. of
Birmingham Med. Sch., U.K.
W79
1174.3 Pregnanolone hemisuccinate inhibits NMDA
receptors with selectivity for the NR1A/2A subtype.
K. Sugunan,
S. Downing, T.T. Gibbs and D.H. Farb. Boston Univ. Sch. of
Med.
W80
1174.4 Affinity and selectivity of luzindole analogs
in mouse and human MT1 and MT2 melatonin receptors
transiently expressed in mammalian cells.
M. Popovska-
Gorevski, K.A. McGowan and M.L. Dubocovich. Univ. at
Buffalo, SUNY.
W81
1174.5 Determination of the site of ligand binding
on the sigma1 receptor.
J.M. Schrock, M.M. Islam, F.J. Kim,
S.G. Grinnell and G.W. Pasternak. Mem. Sloan Kettering and
Drexel Col. of Med.
W82
1174.6 Regulation of potassium-induced [
3
H]
D-aspartate release from isolated bovine retina by 5-epi-5-F
3t
-
isoprostane: role of prostanoid receptors.
C.A. Opere, J. Jamil,
A. Salvi, P. Bankhele, A. Flowers, N. Floyd, T. Durand, J-M.
Galano, A. Guy, C. Oger, Y.F. Njie-Mbye, M. Kulkarni and
S.E. Ohia. Creighton Univ., Biomolec. Inst. Max Mousseron,
Montpellier and Texas Southern Univ.
1175. CELLULAR NEUROPHARMACOLOGY
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W83
1175.1 Characterization of Src and EGFR protein
expression in chronic morphine treated SH-SY5Y cells.
K.
Randell, R. Prenus and C.B. Goodman. Florida A&M Univ.
W84
1175.2 SN79, a sigma receptor ligand, mitigates
methamphetamine-induced astrocyte and microglial activation.
M.J. Robson, R.C. Turner, Z.J. Naser, J.D. Huber, C.R.
McCurdy and R.R. Matsumoto. West Virginia Univ. and Univ.
of Mississippi.
W85
1175.3 Cocaine alters cell cycle activity of rat c6 glial
cells by altering the expression cell cycle regulatory protein.
J.
Triplett, R. Badisa and C.B. Goodman. Florida A&M Univ.
W86
1175.4 Opioid-immune crosstalk: role of microRNA
regulation following opioid and cytokine treatment in normal
human astrocytes.
C.W. Stevens, R.J. Castoro and R.L.
Davis. Oklahoma State Univ. Ctr. for Hlth. Sci.
W87
1175.5 The role of
a- and b-estrogen receptors on
neurite outgrowth in Neuro-2A cells.
M.R. Deshotels, E. Spinu,
E. Bailey and C. Filipeanu. LSU Hlth. Sci. Ctr., New Orleans.
W88
1175.6 Prenatal cocaine exposure inhibits neurite
outgrowth through rage pathway and activates altered
expression of pro-addictive cytokines in primary neuronal and
glial cell cultures.
M.L. Johnson, T. Womble and T.L. Jackson.
Florida A&M Univ.
W89
1175.7 Neuroprotective effects of antioxidants,
idebenone and ferulic acid, in MPTP/MPP
+
intoxicated PC12
cells as a model of Parkinson’s disease.
S. Gupta and K.
Benzeroual. Long Island Univ.
W90
1175.8 Neuroprotective effects of fisetin and diosmetin,
alone and in combination, on lipopolysaccharide-induced
neuronal cells.
P.R. Bhatt and K.E. Benzeroual. Long Island
Univ.
W91
1175.9 The influence of methadone on Toll-like
receptor 4 and human mu opioid receptor expression.
S.
Dodson, S. Das, R. Davis and C.W. Stevens. Oklahoma State
Univ. Ctr. for Hlth. Sci.
1176. SYSTEMS NEUROPHARMACOLOGY
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W92
1176.1 Feedback control of upstream
5-hydroxytryptamine (5-HT) in the dorsal raphe nucleus by
downstream 5-HT2A and AMPA receptors in the prefrontal
cortex.
Z. Zhou, P.G. Chan, J. Sun and J.A. Uchizono. Univ.
of Pacific and Western Univ. of Hlth. Sci.
W93
1176.2 Involvement of 5-HT1A receptors into the
dorsal hippocampus in the hypophagic effect caused by
fluoxetine in rats.
A.A. Scopinho, F.M.A. Corrêa and L.B.M.
Resstel. Univ. of São Paulo, Ribeirão Preto.
W94
1176.3 Uridine enhances in vivo acetylcholine release
in rat striatum.
M. Cansev, E. Orenlili Yaylagul, F. Orhan and
M. Turkyilmaz. Uludag Univ., Turkey.
WEDNESDAY PHARMACOLOGY
416
W95
1176.4 Effects of parabolic flight on serotonin-
related gene expression in the mouse brain.
M. Yoshioka, T.
Yamaguchi, H. Ohta and T. Ochiai. Hokkaido Univ., Nagasaki
Intl. Univ., Torii Pharmaceut. Co. Ltd. and Mitsubishi Heavy
Industry, Kobe, Japan.
W96
1176.5 Presence of octopamine and octopamine
receptors in ganglia and tissues of Crassostrea virginica.
C.
Welsh, F. Bess, E.J. Catapane and M.A. Carroll. Medgar
Evers Col., CUNY.
W97
1176.6 Role of gastrin-releasing peptide and
neuromedin B receptors in the neurotransmission of itch in
the spinal cord of mice.
D. Sukhtankar and M-c. Ko. Univ. of
Michigan Med. Sch.
1177. NEURODEGENERATION/NEUROREGENERATION
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W98
1177.1 Caprylic triglyceride as a novel therapeutic
approach to effectively improve the performance and attenuate
the symptoms due to the motor neuron loss in ALS disease.
G.M. Pasinetti. Mount Sinai Sch. of Med.
W99
1177.2 AAV2/1-mediated gene delivery of CD200
into the hippocampus enhances neurogenesis and amyloid
clearance in the APP mouse.
M.M. Varnum, T. Kiyota, K.
Ingraham, S. Ikezu and T. Ikezu. Boston Univ. Sch. of Med.
and Univ. of Nebraska Med. Ctr.
W100
1177.3 Aged eNOS-/- mice display increased APP
expression, microglial activation, and impaired spatial memory.
S.A. Austin, A.V. Santhanam, D.J. Hinton, D-S. Choi and
Z.S. Katusic. Mayo Clin.
W101
1177.4 The science of repurposing drugs in
Alzheimer’s disease therapeutics: the tale of rexinoid receptor
ligand IRX4204.
G.M. Pasinetti. Mount Sinai Sch. of Med.
W102
1177.5 Identification of brain-targeted bioactive
dietary quercetin-3-O-glucuronide as a novel intervention for
Alzheimer’s disease.
G.M. Pasinetti. Mount Sinai Sch. of Med.
W103
1177.6 Repurposing anti-hypertensive drugs for
Alzheimer’s disease.
G.M. Pasinetti. Mount Sinai Sch. of Med.
W104
1177.7 Chocolate may attenuate cognitive deterioration
in Alzheimer’s disease through prevention of gene expression
related to depressive disorder.
G.M. Pasinetti. Mount Sinai
Sch. of Med.
W105
1177.8 Exogenous T3 administration provides
neuroprotection in a murine model of traumatic brain injury.
I.
Paterniti, R. Crupi, M. Campolo, R. Di Paola, S. Cuzzocrea
and E. Esposito. Univ. of Messina, Italy.
W106
1177.9 Dopamine transporter affects cellular
localization of
a-synuclein. B. Butler, S. Goodwin, M. Zarindast,
S.E. Mehr, S. Hamidi Azghadi and H. Khoshbouei. Univ. of
Florida, Meharry Med. Col. and Tehran Univ. of Med. Sci.
W107
1177.10 Intranasal GDNF for Parkinson’s disease: next
steps in preclinical development.
B.L. Waszczak, L. Wachtman,
G.C. Newsome, A. Aly, N. Silva, S. Westmoreland, J. Rowlett
and M.M. Migliore. Northeastern Univ., Harvard Med. Sch.,
Southborough and Massachusetts Col. of Pharm. and Hlth. Sci.
W108
1177.11
a
1A
adrenergic receptor influences on
progenitor cell fate in the adult hippocampus.
K. Collette, A.
Nielsen, D. Perez and V. Doze. Univ. of North Dakota and
Cleveland Clin. Fndn.
W109
1177.12 The impact of long-term methylphenidate
exposure on neurogenesis in mouse hippocampus.
C. Nguyen,
T. Carter, C. Carothers, A. Hanley and B.B. Pond. Bill Gatton
Col. of Pharm., East Tennessee State Univ.
W110
1177.13 Palmitoylethanolamide enhances brain-
derived neurotrophic factor production and neurogenesis in the
hippocampus following ischemic brain injury.
S. Cuzzocrea,
R. Crupi, I. Paterniti, D. Impellizzeri, M. Campolo and E.
Esposito. Univ. of Messina, Italy.
1178. OCULAR PHARMACOLOGY
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W111
1178.1 Hydrogen sulfide increases aqueous humor
outflow in porcine trabecular meshwork.
J.D. Robinson, Y.F.
Njie-Mbye, A. Okpobiri, M. Chitnis, C.A. Opere and S.E.
Ohia. Texas Southern Univ. and Creighton Univ.
W112
1178.2 Effect of hydrogen sulfide on isolated bovine
ocular smooth muscle.
A.C. Okpobiri, Y.F. Njie-Mbye, J.
Robinson, M. Chitnis, C. Opere and S. Ohia. Univ. of Texas
at Austin, Texas Southern Univ. and Creighton Univ.
W113
1178.3 Elevation of lysosomal pH leads to the release
of Ca
2+
, ATP and cytokines from RPE cells.
C.H. Mitchell, S.
Guha, J.M. Beckel and A.M. Laties. Univ. of Pennsylvania.
W114
1178.4 Prenatal hypoxia causes long-term retina
dysfunction in rats.
S.L. Bourque, S. Kuny, Y. Sauve and S.T.
Davidge. Univ. of Alberta.
W115
1178.5 Role of the Krebs cycle metabolites in retinal
angiogenesis.
F. Duhamel, K. Zaniolo, H. Tahiri and S.
Chemtob. Univ. of Montreal and CHU Ste-Justine Res. Ctr.,
Montreal.
W116
1178.6 Regulation by RhoA of Rod photoreceptor
axon retraction induced by retinal detachment.
W. Wang and
E. Townes-Anderson. UMDNJ, Newark.
1179. GENERAL TOXICOLOGY
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W117
1179.1 Safety evaluation of a second generation
enzyme replacement therapy.
A.L. D’Angona, P. Finn,
J. Murray, A. McVie-Wylie and L. Andrews. Genzyme,
Framingham, MA.
W118
1179.2 Cytotoxic effects of manganese in human
prostate carcinoma DU145 cells.
V. Idikuda, M. Lai, J. Pfau, A.
Bhushan, S. Leung and J. Lai. Idaho State Univ.
W119
1179.3 Chelating agents reverse neurotoxic effects of
manganese on dopaminergic innervation of gill of the bivalve
mollusc Crassostrea virginica.
C. Ojo, K. Rogers, T. Adams,
E.J. Catapane and M.A. Carroll. Medgar Evers Col., CUNY.
W120
1179.4 Mrp1 protects against doxorubicin-induced
cardiotoxicity in vitro.
W. Zhang, D. Coy, J. Deng and M. Vore.
Univ. of Kentucky.
PHARMACOLOGY WEDNESDAY
417
W
E
D
W121
1179.5 Cleavage of ROCK II: as a common
phenomenon in cell death.
A. Ozdemir, B. Ibisoglu, Y.D.
Simay, B. Mitrovic Yaren and M. Ark. Gazi Univ. Fac. of
Pharm., Turkey.
W122
1179.6 Potential inflammatory effects of levodopa –
insights into Parkinson’s disease therapy.
E.M.G. Allen and
J.J. Mieyal. Case Western Reserve Univ. and Louis B. Stokes
VA Med. Res. Ctr.
W123
1179.7 Acute doxorubicin treatment induces proteome
lysine deacetylation, with no change in sirtuin expression,
in the heart and liver of fasted animals.
A.J. Dirks-Naylor,
J.D. Bero, S. Yang, R. Mabolo, N.T.K. Tran and S.A. Kouzi.
Wingate Univ. Sch. of Pharm., NC.
1180. GENE REGULATION AND EXPRESSION
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W124
1180.1 PKC phosphorylation of Med25 is critical for
mediator assembly: implications for HNF4
a signaling in drug
metabolism.
S-Y. Zhang, S. Surapureddi and J.A. Goldstein.
NIEHS, NIH, Research Triangle Park.
W125
1180.2 Selective estrogen receptor modulators
tamoxifen, pterostilbene, raloxifene and clomiphene fail to
stimulate the hepatic expression of estrogen responsive
genes encoding the avian apolipoprotein II and vitellogenin.
V.D. Bhatt and W.N. Ratna. Arnold & Marie Schwartz Col. of
Pharm., Long Island Univ.
W126
1180.3 Regulation and function of CYP2B6 in a
CYP2A13/2B6/2F1-transgenic mouse model.
Z. Liu, L. Li, H.
Wu and X. Ding. New York State Dept. of Hlth. and SUNY at
Albany.
W127
1180.4 Regulation of MOR-1A, an intron-retention
splice variant of the mu opioid receptor (OPRM1) gene, by
miR-107.
Z. Lu, J. Xu, M. Xu, G.W. Pasternak and Y-X. Pan.
Mem. Sloan-Kettering Cancer Ctr.
W128
1180.5 Identification of regulatory RNA binding
proteins that mediate alternative polyadenylation in cardiac
myocytes.
L. Smith, M. McGuinness, W. Paulding, A.
Roessler, A. Gabanic, M. Kelley, L. Haar and M. Tranter. Univ.
of Cincinnati and Xavier Univ., OH.
W129
1180.6 Dietary regulation of mouse intestinal P450
expression and drug metabolism.
Q-Y. Zhang, P. Zhang, K.
Jia, C. Fang, X. Zhou and X. Ding. NYS Dept. of Hlth., Albany
and SUNY at Albany.
W130
1180.7 Effects of radiation exposure and dietary iron
on liver metabolic gene expression.
V.E. Wotring. NASA,
Houston.
W131
1180.8 A novel redox-based epigenetic signaling
mechanism for opioids.
M. Trivedi, N. Hodgson, J. Shah and
R. Deth. Northeastern Univ.
W132
1180.9 A major compound isolated from Undaria
pinnatifida downregulates CYP3A4 and MDR1 expression by
antagonizes pregnane X receptor activation.
Y.P. Lim, C.L. Liu
and M.L. Hu. China Med. Univ. and Natl. Chung Hsing Univ.,
Taiwan.
W133
1180.10 Alternative polyadenylation mediated
shortening of the Hsp70.3 3’UTR increases polyribosome
loading of the mRNA transcript.
A. Gabanic, W. Paulding,
A. Roessler, K. Luther, L. Smith, M. McGuinness and M.
Tranter. Univ. of Cincinnati and Xavier Univ., OH.
W134
1180.11 Transcription factor BCL11B enforces
asymmetric enamel-secreting cell development in the mouse
incisor by bidirectional regulation of gene expression.
K.
Kyrylkova, S. Kyryachenko, C. Kioussi and M. Leid. Oregon
State Univ.
1181. STEM CELLS AND REGENERATIVE MEDICINE
Poster
W
eD
. 7:30
am
—B
oston
C
onvention
& e
xhiBition
C
enter
,
e
xhiBit
h
alls
a-B
Presentation time: 12:30
pm
-2:30
pm
W135
1181.1 MALT lymphoma stem cell and its niche in
Helicobacter heilmannii-infected mice stomach.
M. Nakamura,
H. Matsui, T. Takahashi, K. Tsuchimoto and S. Takahashi.
Kitasato Univ. and Kyorin Univ., Tokyo and Mitaka, Japan.
W136
Dostları ilə paylaş: |